Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1787011
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1787011
Radiopharmaceuticals Market Size, Share, Trends, & Industry Analysis Report By Radioisotope Type (Technetium-99, Fluorine-18), By Application, By Source, By End User, and By Region - Market Forecast, 2025-2034
PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The radiopharmaceuticals market size is expected to reach USD 20.94 Billion by 2034, according to a new study by Polaris Market Research. The report "Radiopharmaceuticals Market Size, Share, Trends, & Industry Analysis Report By Radioisotope Type (Technetium-99, Fluorine-18), By Application, By Source, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The radiopharmaceuticals market is growing steadily as hospitals and imaging centers increasingly rely on nuclear medicine for both diagnosis and treatment. These specialized compounds are used in scans such as PET and SPECT to detect conditions early and accurately.
Ongoing research is leading to the development of new radiopharmaceuticals that are more precise and contains fewer side effects. Therefore, healthcare providers are investing in modern imaging systems and expanding nuclear medicine departments. This shift is improving patient outcomes, providing advanced diagnostic and therapeutic services.
Radiopharmaceuticals Market Report Highlights
Based on radioisotope type, the technetium-99 segment dominated the market in 2024, due to its widespread application in SPECT imaging for conditions related to bone, cardiac, and oncology diagnostics.
In terms of application, the neurology segment dominated the market in 2024. This is owing the growing adoption of radiopharmaceuticals in cancer diagnosis, staging, and treatment planning.
In terms of source, the nuclear reactors segment dominated the market in 2024, due to the extensive use of isotopes such as molybdenum-99.
North America accounted for the majority share in the global Radiopharmaceuticals market in 2024, due to advanced nuclear medicine infrastructure.
Asia Pacific held substantial market share, owing to rapid growth in healthcare infrastructure across India, China, and South Korea.
A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.
Polaris Market Research has segmented the market report on the basis of type, application, source, end user, and region:
By Radioisotope Type Outlook (Revenue, USD Billion, 2020-2034)
Technetium-99
Fluorine-18
Iodine-131
Lutetium-177
Yttrium-90
Gallium-68
Gallium-67
Rubidium-82
Iodine-123
Iodine-125
Indium-111
Others
By Application Outlook (Revenue, USD Billion, 2020-2034)
Oncology
Cardiology
Gastroenterology
Neuroendocrinology
Neurology
Nephrology
Others
By Source Outlook (Revenue, USD Billion, 2020-2034)
Nuclear Reactors
Cyclotrons
By End User Outlook (Revenue, USD Billion, 2020-2034)
Hospitals
Diagnostic Centers
Cancer Research Institutes
Ambulatory Surgical Centers
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Product Code: PM6029
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Radiopharmaceuticals Market Insights
- 4.1. Radiopharmaceuticals Market - Market Snapshot
- 4.2. Radiopharmaceuticals Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Number of Cancer and Cardiovascular Diseases Globally
- 4.2.1.2. Aging Global Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Production Costs and Complex Regulatory Approvals
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Radiopharmaceuticals Market Trends
- 4.6. Value Chain Analysis
5. Global Radiopharmaceuticals Market, by Radioisotope Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 5.3. Technetium-99
- 5.3.1. Global Radiopharmaceuticals Market, by Technetium-99, by Region, 2020-2034 (USD Billion)
- 5.4. Fluorine-18
- 5.4.1. Global Radiopharmaceuticals Market, by Fluorine-18, by Region, 2020-2034 (USD Billion)
- 5.5. Iodine-131
- 5.5.1. Global Radiopharmaceuticals Market, by Iodine-131, by Region, 2020-2034 (USD Billion)
- 5.6. Lutetium-177
- 5.6.1. Global Radiopharmaceuticals Market, by Lutetium-177, by Region, 2020-2034 (USD Billion)
- 5.7. Yttrium-90
- 5.7.1. Global Radiopharmaceuticals Market, by Yttrium-90, by Region, 2020-2034 (USD Billion)
- 5.8. Gallium-68
- 5.8.1. Global Radiopharmaceuticals Market, by Gallium-68, by Region, 2020-2034 (USD Billion)
- 5.9. Gallium-67
- 5.9.1. Global Radiopharmaceuticals Market, by Gallium-67, by Region, 2020-2034 (USD Billion)
- 5.10. Rubidium-82
- 5.10.1. Global Radiopharmaceuticals Market, by Rubidium-82, by Region, 2020-2034 (USD Billion)
- 5.11. Iodine-123
- 5.11.1. Global Radiopharmaceuticals Market, by Iodine-123, by Region, 2020-2034 (USD Billion)
- 5.12. Iodine-125
- 5.12.1. Global Radiopharmaceuticals Market, by Iodine-125, by Region, 2020-2034 (USD Billion)
- 5.13. Indium-111
- 5.13.1. Global Radiopharmaceuticals Market, by Indium-111, by Region, 2020-2034 (USD Billion)
- 5.14. Others
- 5.14.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Radiopharmaceuticals Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 6.3. Oncology
- 6.3.1. Global Radiopharmaceuticals Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 6.4. Cardiology
- 6.4.1. Global Radiopharmaceuticals Market, by Cardiology, by Region, 2020-2034 (USD Billion)
- 6.5. Gastroenterology
- 6.5.1. Global Radiopharmaceuticals Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
- 6.6. Neuroendocrinology
- 6.6.1. Global Radiopharmaceuticals Market, by Neuroendocrinology, by Region, 2020-2034 (USD Billion)
- 6.7. Neurology
- 6.7.1. Global Radiopharmaceuticals Market, by Neurology, by Region, 2020-2034 (USD Billion)
- 6.8. Nephrology
- 6.8.1. Global Radiopharmaceuticals Market, by Nephrology, by Region, 2020-2034 (USD Billion)
- 6.9. Others
- 6.9.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Radiopharmaceuticals Market, by Source Outlook
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 7.3. Nuclear Reactors
- 7.3.1. Global Radiopharmaceuticals Market, by Nuclear Reactors, by Region, 2020-2034 (USD Billion)
- 7.4. Cyclotrons
- 7.4.1. Global Radiopharmaceuticals Market, by Cyclotrons, by Region, 2020-2034 (USD Billion)
8. Global Radiopharmaceuticals Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Radiopharmaceuticals Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 8.4. Diagnostic Centers
- 8.4.1. Global Radiopharmaceuticals Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
- 8.5. Cancer Research Institutes
- 8.5.1. Global Radiopharmaceuticals Market, by Cancer Research Institutes, by Region, 2020-2034 (USD Billion)
- 8.6. Ambulatory Surgical Centers
- 8.6.1. Global Radiopharmaceuticals Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
- 8.7. Others
- 8.7.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Radiopharmaceuticals Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Radiopharmaceuticals Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Radiopharmaceuticals Market - North America
- 9.3.1. North America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.3.3. North America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.3.4. North America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Radiopharmaceuticals Market - U.S.
- 9.3.5.1. U.S.: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.3.5.2. U.S.: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.3.5.3. U.S.: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.3.5.4. U.S.: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Radiopharmaceuticals Market - Canada
- 9.3.6.1. Canada: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4. Radiopharmaceuticals Market - Europe
- 9.4.1. Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.3. Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.4. Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Radiopharmaceuticals Market - UK
- 9.4.5.1. UK: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Radiopharmaceuticals Market - France
- 9.4.6.1. France: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.6.2. France: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.6.3. France: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.6.4. France: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Radiopharmaceuticals Market - Germany
- 9.4.7.1. Germany: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Radiopharmaceuticals Market - Italy
- 9.4.8.1. Italy: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Radiopharmaceuticals Market - Spain
- 9.4.9.1. Spain: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Radiopharmaceuticals Market - Netherlands
- 9.4.10.1. Netherlands: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Radiopharmaceuticals Market - Russia
- 9.4.11.1. Russia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Radiopharmaceuticals Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5. Radiopharmaceuticals Market - Asia Pacific
- 9.5.1. Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Radiopharmaceuticals Market - China
- 9.5.5.1. China: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.5.2. China: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.5.3. China: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.5.4. China: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Radiopharmaceuticals Market - India
- 9.5.6.1. India: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.6.2. India: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.6.3. India: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.6.4. India: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Radiopharmaceuticals Market - Malaysia
- 9.5.7.1. Malaysia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Radiopharmaceuticals Market - Japan
- 9.5.8.1. Japan: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Radiopharmaceuticals Market - Indonesia
- 9.5.9.1. Indonesia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Radiopharmaceuticals Market - South Korea
- 9.5.10.1. South Korea: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Radiopharmaceuticals Market - Australia
- 9.5.11.1. Australia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Radiopharmaceuticals Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.6. Radiopharmaceuticals Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Radiopharmaceuticals Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Radiopharmaceuticals Market - UAE
- 9.6.6.1. UAE: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Radiopharmaceuticals Market - Israel
- 9.6.7.1. Israel: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Radiopharmaceuticals Market - South Africa
- 9.6.8.1. South Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Radiopharmaceuticals Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.7. Radiopharmaceuticals Market - Latin America
- 9.7.1. Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Radiopharmaceuticals Market - Mexico
- 9.7.5.1. Mexico: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Radiopharmaceuticals Market - Brazil
- 9.7.6.1. Brazil: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Radiopharmaceuticals Market - Argentina
- 9.7.7.1. Argentina: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Radiopharmaceuticals Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Advanced Accelerator Applications SA
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. AstraZeneca plc
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bayer AG
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Boehringer Ingelheim International GmbH
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Bracco Imaging S.p.A.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Cardinal Health, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Curium Pharma
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Eckert & Ziegler SE
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. F. Hoffmann-La Roche Ltd
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. GE HealthCare Technologies Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. GlaxoSmithKline plc (GSK plc)
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Jubilant Radiopharma Limited
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
Product Code: PM6029
List of Tables:
- Table 1 Global Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 2 Global Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 3 Global Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 4 Global Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 5 North America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 6 North America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 7 North America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 8 North America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 9 U.S.: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 10 U.S.: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 11 U.S.: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 12 U.S.: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 13 Canada: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 14 Canada: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 15 Canada: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 16 Canada: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 17 Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 18 Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 19 Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 20 Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 21 UK: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 22 UK: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 23 UK: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 24 UK: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 25 France: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 26 France: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 27 France: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 28 France: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 29 Germany: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 30 Germany: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 31 Germany: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 32 Germany: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 33 Italy: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 34 Italy: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 35 Italy: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 36 Italy: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 37 Spain: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 38 Spain: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 39 Spain: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 40 Spain: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 41 Netherlands: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 42 Netherlands: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 43 Netherlands: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 44 Netherlands: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 45 Russia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 46 Russia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 47 Russia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 48 Russia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 49 Rest of Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 50 Rest of Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 51 Rest of Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 52 Rest of Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 53 Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 54 Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 55 Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 56 Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 57 China: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 58 China: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 59 China: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 60 China: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 61 India: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 62 India: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 63 India: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 64 India: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 65 Malaysia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 66 Malaysia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 67 Malaysia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 68 Malaysia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 69 Japan: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 70 Japan: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 71 Japan: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 72 Japan: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 73 Indonesia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 74 Indonesia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 75 Indonesia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 76 Indonesia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 77 South Korea: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 78 South Korea: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 79 South Korea: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 80 South Korea: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 81 Australia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 82 Australia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 83 Australia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 84 Australia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 85 Rest of Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 86 Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 87 Rest of Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 88 Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 89 Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 90 Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 91 Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 92 Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 93 Saudi Arabia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 94 Saudi Arabia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 95 Saudi Arabia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 96 Saudi Arabia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 97 UAE: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 98 UAE: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 99 UAE: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 100 UAE: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 101 Israel: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 102 Israel: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 103 Israel: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 104 Israel: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 105 South Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 106 South Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 107 South Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 108 South Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 109 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 110 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 111 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 112 Rest of Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 113 Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 114 Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 115 Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 116 Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 117 Mexico: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 118 Mexico: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 119 Mexico: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 120 Mexico: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 121 Brazil: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 122 Brazil: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 123 Brazil: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 124 Brazil: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 125 Argentina: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 126 Argentina: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 127 Argentina: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 128 Argentina: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
- Table 129 Rest of Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
- Table 130 Rest of Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
- Table 131 Rest of Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
- Table 132 Rest of Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
List of Figures:
- Figure 1. Global Radiopharmaceuticals Market, 2020-2034 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Radioisotope Type
- Figure 7. Global Radiopharmaceuticals Market, by Radioisotope Type, 2024 & 2034 (USD Billion)
- Figure 8. Market by Application
- Figure 9. Global Radiopharmaceuticals Market, by Application, 2024 & 2034 (USD Billion)
- Figure 10. Market by Source Outlook
- Figure 11. Global Radiopharmaceuticals Market, by Source Outlook, 2024 & 2034 (USD Billion)
- Figure 12. Market by End User
- Figure 13. Global Radiopharmaceuticals Market, by End User, 2024 & 2034 (USD Billion)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.